OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 126 filers reported holding OLEMA PHARMACEUTICALS INC in Q1 2024. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 4,383,875 | $49,625,465 | 4.02% |
| MPM BioImpact LLC | 1,953,690 | $22,115,771 | 3.56% |
| Ally Bridge Group (NY) LLC | 559,035 | $6,328,276 | 3.52% |
| Paradigm Biocapital Advisors LP | 7,903,600 | $89,468,752 | 3.15% |
| BVF INC/IL | 9,135,893 | $103,418,309 | 2.84% |
| Altium Capital Management LP | 605,000 | $6,848,600 | 2.71% |
| Vivo Capital, LLC | 1,873,704 | $21,210,329 | 1.67% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 515,317 | $5,833,388 | 1.62% |
| Exome Asset Management LLC | 143,400 | $1,623,288 | 1.39% |
| Deep Track Capital, LP | 3,225,419 | $36,511,743 | 1.05% |
| HighVista Strategies LLC | 247,880 | $2,806,002 | 1.00% |
| Ghost Tree Capital, LLC | 200,000 | $2,264,000 | 0.63% |
| SECTORAL ASSET MANAGEMENT INC | 139,980 | $1,584,574 | 0.62% |
| Soleus Capital Management, L.P. | 658,000 | $7,448,560 | 0.55% |
| Newtyn Management, LLC | 150,000 | $1,698,000 | 0.34% |
| BRAIDWELL LP | 704,344 | $7,973,174 | 0.26% |
| Monashee Investment Management LLC | 135,000 | $1,528,200 | 0.18% |
| EntryPoint Capital, LLC | 14,530 | $164,480 | 0.15% |
| Atom Investors LP | 94,321 | $1,067,714 | 0.13% |
| Woodline Partners LP | 750,279 | $8,493,158 | 0.08% |
External links
This page lists OLEMA PHARMACEUTICALS INC's shareholders in Q1 2024. To view OLEMA PHARMACEUTICALS INC's shareholder history, click here.